CA2470935A1 - Polyene oxazoles and processes for their preparation - Google Patents

Polyene oxazoles and processes for their preparation Download PDF

Info

Publication number
CA2470935A1
CA2470935A1 CA002470935A CA2470935A CA2470935A1 CA 2470935 A1 CA2470935 A1 CA 2470935A1 CA 002470935 A CA002470935 A CA 002470935A CA 2470935 A CA2470935 A CA 2470935A CA 2470935 A1 CA2470935 A1 CA 2470935A1
Authority
CA
Canada
Prior art keywords
compound
pharmaceutically acceptable
cancer cell
growth
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002470935A
Other languages
English (en)
French (fr)
Inventor
James B. Mcalpine
Nargis Ismail
Chris M. Farnet
Emmanuel Zazopoulos
Brian O. Bachmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thallion Pharmaceuticals Inc
Original Assignee
Ecopia Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecopia Biosciences Inc filed Critical Ecopia Biosciences Inc
Publication of CA2470935A1 publication Critical patent/CA2470935A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/60—Streptomyces sparsogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002470935A 2003-06-13 2004-06-14 Polyene oxazoles and processes for their preparation Abandoned CA2470935A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47793103P 2003-06-13 2003-06-13
USUSSN60/477,931 2003-06-13

Publications (1)

Publication Number Publication Date
CA2470935A1 true CA2470935A1 (en) 2004-12-13

Family

ID=33551785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002470935A Abandoned CA2470935A1 (en) 2003-06-13 2004-06-14 Polyene oxazoles and processes for their preparation

Country Status (7)

Country Link
US (2) US7312339B2 (enExample)
EP (1) EP1633352B1 (enExample)
JP (1) JP2006527208A (enExample)
AT (1) ATE344032T1 (enExample)
CA (1) CA2470935A1 (enExample)
DE (1) DE602004003056D1 (enExample)
WO (1) WO2004110439A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2512240T3 (es) * 2009-07-14 2014-10-23 Takasago International Corporation Método para preparar espilantol y producto intermedio para su preparación
CN107478670B (zh) * 2017-08-08 2018-04-03 中国环境科学研究院 一种沉积物中肌醇磷酸盐与腐殖酸相互作用的分析方法
CN112067647B (zh) * 2020-11-11 2021-01-15 东南大学 一种检测液体生物样本葡萄糖含量的弛豫核磁共振方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364198A (en) * 1964-10-12 1968-01-16 Upjohn Co Process for the production of n6-methyltubercidin and intermediate
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS6081184A (ja) * 1983-10-11 1985-05-09 Banyu Pharmaceut Co Ltd 抗腫瘍性抗生物質及びその製法
JPS61172881A (ja) * 1985-01-26 1986-08-04 Meiji Seika Kaisha Ltd 新抗生物質キューロマイシンａ又はｂとその製造法
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
JPH08176116A (ja) * 1994-12-27 1996-07-09 Rikagaku Kenkyusho 新規抗生物質スパロキソマイシン
JP2003514033A (ja) * 1999-11-15 2003-04-15 パーカー ヒューズ インスティテュート 癌治療用のホルボキサゾール誘導体

Also Published As

Publication number Publication date
EP1633352A1 (en) 2006-03-15
DE602004003056D1 (de) 2006-12-14
JP2006527208A (ja) 2006-11-30
WO2004110439A1 (en) 2004-12-23
US7312339B2 (en) 2007-12-25
US20090069396A1 (en) 2009-03-12
ATE344032T1 (de) 2006-11-15
US20050038090A1 (en) 2005-02-17
EP1633352B1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
AU2004212296B2 (en) Substituted heterocycles
EP1585752B1 (en) Polyene polyketides, processes for their production and their use as a pharmaceutical
US4946941A (en) Novel glycopeptide antibiotics
Harris et al. Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs
EP2097423B1 (en) Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
EP1651628B1 (en) Antibiotic compound
US20090069396A1 (en) Polyene Oxazoles and Processes for Their Preparation
CA2467249C (en) Polyene polyketides, processes for their production and their use as pharmaceuticals
US20050215490A1 (en) Polyene polyketides and methods of treating bacterial infections
JPWO2005061461A1 (ja) ヒートショックプロテイン９０（ｈｓｐ９０）ファミリー蛋白質阻害剤
EP0802920B1 (en) Antifungal fusacandins
US6004952A (en) Micacocidin derivatives
JP2013542173A (ja) 新規抗菌性化合物、それらの作製法、およびそれらの使用
KR20010086006A (ko) 반코레스마이신, 이의 제조방법 및 약제로서의 이의 용도
US5334613A (en) Antibacterial substance BE-24566B
RU2261916C2 (ru) Амикомицин, способ его получения и его применение в качестве фармацевтического средства
WO2006047891A1 (en) Polycyclic aromatics and derivatives thereof and processes for their preparation
MXPA03002343A (es) Citrulimicinas, un proceso para su produccion y su empleo como productos farmaceuticos.
JPWO1998045320A1 (ja) 新規ヘキサデプシペプチド化合物
WO2008024285A2 (en) Antibiotic compound
JP2006213703A (ja) 新規発酵生産物
WO2011136174A1 (ja) デプシペプチド化合物
WO1998045320A1 (fr) Nouveaux composes d'hexadepsipeptides
JP2006089390A (ja) キガマイシノン類及びその製造方法、並びに、該キガマイシノン類を含む薬用組成物
JPH08176116A (ja) 新規抗生物質スパロキソマイシン

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued